ABC | Volume 114, Nº5, May 2020

Original Article Silva et al. Florida Shock Anxiety Scale Arq Bras Cardiol. 2020; 114(5):764-772 1. Al-Khatib SM, Friedman P, Ellenbogen KA. Defibrillators: Selecting the Right Device for the Right Patient. Circulation. 2016;134(18):1390-404. 2. Colquitt JL, Mendes D, Clegg AJ, Harris P, Cooper K, Picot J, Bryant J. Implantable cardioverter defibrillators for the treatment of arrhythmias and cardiac resynchronization therapy for the treatment of heart failure: systematic review and economic evaluation. Health Technol Assess. 2014;18(56):1-560. 3. Winkle RA. Evolution of the implantable cardioverter-defibrillator: from bullets to BBs. J Am Coll Cardiol 2012;60(23):2399-401. 4. CammAJ, NisamS. European utilization of the implantable defibrillator: has 10 years changed the “enigma”? Europace 2010;12:1063-9. 5. Wilkoff BL, Fauchier L, Stiles MK, Morillo CA, Al-Khatib SM, Almendral J, et al. 2015 HRS/EHRA/APHRS/ SOLAECE Expert consensus statement on optimal implantable cardioverter-defibrillator programming and testing. Heart Rhythm. 2016;13(2):e50–e86. 6. Daubert JP, Zareba W, Cannom DS, McNitt S, Rosero SZ, Wang P, et al. Inappropriate implantable cardioverter-defibrillator shocks in MADIT II: frequency, mechanisms, predictors, and survival impact. J AmColl Cardiol. 2008;51(14):1357-65. 7. Sood N, Ruwald AC, Solomon S, Daubert JP, McNitt S, Polonsky B, et al. Association between myocardial substrate, implantable cardioverter defibrillator shocks and mortality in MADIT-CRT. Eur Heart J. 2014;35(2):106-15. 8. Desai H, AronowWS, AhnC, Gandhi K, Hussain S, Lai HM, et al. Risk factors for appropriate cardioverter-defibrillator shocks, inappropriate cardioverter- defibrillator shocks, and time to mortality in 549 patients with heart failure. Am J Cardiol. 2010;105(9):1336-8. 9. Ahmad M, Bloomstein L, Roelke M, Bernstein AD, Parsonnet V. Patients’ attitudes towards implanted defibrillator shocks. Pacing Clin Electrophysiol 2000; 23(6):934–8. 10. Costa R, Silva KR, Mendonça RC, Nishioka SA, Siqueira SF, Tamaki WT, et al. Incidence of shock and quality of life in young patients with implantable cardioverter-defibrillator. Arq Bras Cardiol. 2007;88(3):258-64. 11. Pedersen SS, Sears SF, Burg MM, Van Den Broek KC. Does ICD indication affect quality of life and levels of distress? Pacing Clin Electrophysiol. 2009; 32(2):153-6. 12. Sears SF, Conti JB. Quality of life and psychological functioning of ICD patients. Heart 2002; 87(5): 488–93. 13. Carroll SL, Strachan PH, de Laat S, Schwartz L, Arthur HM. Patients’ decision making to accept or decline an implantable cardioverter defibrillator for primary prevention of sudden cardiac death. Health Expect 2013;16(1):69-79 14. da Silva KR, Costa R, Rodrigues CG, Schasechter A, Nobre MC, Passman R, et al. Quality of life in patients with implantable cardioverter-defibrillator: systematic review of randomized controlled trials. Eur J Cardiovasc Nurs. 2018;17(3):196-206. 15. Kuhl EA, Dixit NK, Walker RL, Conti JB, Sears SF. Measurement of patient fears about implantable cardioverter defibrillator shock: an initial evaluation of the Florida Shock Anxiety Scale. Pacing Clin Electrophysiol. 2006;29(6):614-8. 16. Ford J, Finch JF, Woodrow LK, Cutitta KE, Shea J, Fischer A, et al. The Florida Shock Anxiety Scale (FSAS) for patients with implantable cardioverter defibrillators: testing factor structure, reliability, and validity of a previously established measure. Pacing Clin Electrophysiol. 2012;35(9):1146-53. 17. Versteeg H, Starrenburg A, Denollet J, Palen Jv, Sears SF, Pedersen SS. Monitoring device acceptance in implantable cardioverter defibrillator patients using the Florida Patient Acceptance Survey. Pacing Clin Electrophysiol. 2012;35(3):283-93. 18. Pedersen SS, Spindler H, Johansen JB, Mortensen PT, Sears SF. Correlates of patient acceptance of the cardioverter defibrillator: cross-validation of the Florida Patient Acceptance Survey in Danish patients. Pacing Clin Electrophysiol. 2008;31(9):1168-77 19. Kocha ń ska A, Zarzycka B, Ś wi ą tecka G, MajkowiczM, Kozłowski D, Raczak G.Quality of life in patients with an implantable cardioverter-defibrillator – the significance of clinical factors. Arch Med Sci 2008; 4(4):409-16. 20. Chair SY, Lee CK, Choi KC, Sears SF. Quality of life outcomes in chinese patients with implantable cardioverter defibrillators. Pacing Clin Electrophysiol. 2011;34(7):858-67 21. Morken IM, Isaksen K, Karlsen B, Norekvål TM, Bru E, Larsen AI. Shock anxiety among implantable cardioverter defibrillator recipients with recent tachyarrhythmia. Pacing Clin Electrophysiol. 2012;35(11):1369-76 22. Oz AlkanH, Enç N. Validity and reliability of the Florida Patient Acceptance Survey and Florida Shock Anxiety Scale in Turkish patients with implantable cardioverter defibrillation. Int J Med Res Health Sci 2017,6(10):21-32. 23. WildD,GroveA,MartinM.Principlesofgoodpractice forthetranslationand cultural adaptation process for patient-reported outcomes (PRO) measures: report of the ISPOR task force for translating adaptation. Value Health> 2005;8(2):94-104. 24. BeatonD, Bombardier C, Guillemin F, FerrazMB. Guidelines for the process of cross-cultural adaptation of self-report measures. Spine (Phila Pa 1976). 2000;25(24):3186-91. 25. Sousa VD, Rojjanasrirat WJ. Translation, adaptation and validation of instruments or scales for use in cross-cultural health care research: a clear and user-friendly guideline. Eval Clin Pract. 2011;17(2):268-74. 26. Harris PA, Taylor R, Thielke R, Payne J, Gonzalez N, Conde JG. Research electronic data capture (REDCap) - A metadata-driven methodology and workflow process for providing translational research informatics support, J Biomed Inform. 2009;42(2):377-81. References Potential Conflict of Interest No potential conflict of interest relevant to this article was reported. Sources of Funding Th i s s t udy wa s f unded by FAPESP. (Gr an t # 2016/02104-6). Study Association This study is not associated with any thesis or dissertation. Ethics approval and consent to participate This study was approved by the Ethics Committee o f t h e CAPPe s q und e r t h e p r o t o c o l numb e r CAAE:54522516.2.000.0068. All the procedures in this study were in accordance with the 1975 Helsinki Declaration, updated in 2013. Informed consent was obtained from all participants included in the study. 771